Evaluating SNVs and insertion/deletion events across a landscape of genes or gene regions with established potential in lymphoma (Supplemental Tables 5 and 6), mutations affecting KMT2D, PCLO, IGLL5, TP53, and CREBBP were most frequently observed in rrDLBCL tumors (Fig. 1A). The gene discussed is TP53; the disease is lymphoma.